134 related articles for article (PubMed ID: 3945435)
1. Treatment of hyperprolactinemic amenorrhea with Metergoline.
Bohnet HG; Kato K; Wolf AS
Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
[TBL] [Abstract][Full Text] [Related]
2. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
[TBL] [Abstract][Full Text] [Related]
3. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
[TBL] [Abstract][Full Text] [Related]
4. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Farrari C; Telloli P; Rampini P; Caldara R
Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
[TBL] [Abstract][Full Text] [Related]
6. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
[No Abstract] [Full Text] [Related]
7. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
[TBL] [Abstract][Full Text] [Related]
8. Metergoline as an alternative to bromocriptine in amenorrhoea.
Hicks BH; Finer N; Herbert LC
Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
[TBL] [Abstract][Full Text] [Related]
9. The effect of the ergoline derivative, CU 32-085, on prolactin secretion in hyperprolactinemic women.
Hesla JS; Rodman EF; Molitch ME; Goodman LA; Chang RJ
Fertil Steril; 1987 Oct; 48(4):555-9. PubMed ID: 3653414
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
Schneider WH; Huber H; Spona J
Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
[TBL] [Abstract][Full Text] [Related]
11. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases].
Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C
Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283
[No Abstract] [Full Text] [Related]
12. Metergoline treatment of hyperprolactinemic states.
Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E
Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408
[No Abstract] [Full Text] [Related]
13. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
[No Abstract] [Full Text] [Related]
14. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
Holtkamp W; Nagel GA
Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
Falsetti L; Scagliola P; Turla R; Voltolini AM
Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
[TBL] [Abstract][Full Text] [Related]
18. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
[TBL] [Abstract][Full Text] [Related]
19. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
Ciccarelli E; Giusti M; Miola C; Potenzoni F; Sghedoni D; Camanni F; Giordano G
J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
